Search for: "PFIZER" Results 3041 - 3060 of 4,635
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Apr 2014, 8:13 am by Jocelyn Hutton, Matrix
On Thursday 1 May, also in Court 3 at 10.30 is the Jamaican appeal of Pfizer Ltd v Medimpex Jamaica Ltd & Anor on whether a Jamaican patent, owned by Pfizer for the invention salts of amlodipine/amlodipine besylate is valid. [read post]
13 Apr 2010, 11:26 am
Pfizer paid $35 million in 6 months to “independent” doctors that promoted Pfizer’s products. [read post]
30 Jun 2016, 12:12 pm by Tom Lamb
Non-clinical studies have demonstrated reversal of all approved NOACs including Daiichi Sankyo's SavaysaTM/Lixiana® (edoxaban), Boehringer Ingelheim's Pradaxa® (dabigatran etexilate), Johnson & Johnson and Bayer's Xarelto® (rivaroxaban), and Bristol-Myers Squibb and Pfizer's Eliquis® (apixaban). [read post]
  Here, defendant Pfizer Inc. produced an affidavit stating that sales from the relevant Advil products were over $14 million, and defendants Johnson & Johnson and McNeil-PPC Inc. produced an affidavit stating their total sales of Tylenol Cold Multi-Symptom were $3.3 million. [read post]
22 Jun 2011, 4:09 am by Marie Louise
(BIOtechNow) US: Manager’s Amendment (and others) to H.R. 1249 — Second opinions in genetic diagnostic testing (Patent Docs) US: AMA, ACLU and their friends oppose (Leahy-Smith) America Invents Act (Patent Docs) US: Kaneka files new 337 complaint regarding Certain Coenzyme Q10 Products (ITC 337 Law Blog) Products Baytril (Enrofloxacin) – US: In a rare move, District Court extends 30-month stay on FDA ANADA approval: Bayer Healthcare v Norbrook (FDA Law Blog) Cialis (Tadalafil)… [read post]
12 Dec 2008, 7:00 am
EU: European Commission preliminary report on its inquiry into competition in the pharmaceutical sector (Spicy IP) (Intellectual Property Watch) (Patent Baristas) EU: Enlarged Board of the EPO denies WARF’s patent application directed to human embryonic stem cells (Patent Docs) US: Patent Office assault on pharma industry (PLI) US: Proponent of gene patent ban Rep Xavier Becerra to leave Congress (Patent Docs) US: Merck & Co starts generic arm BioVentures to copy biologic medicine… [read post]
23 Jun 2015, 10:56 am by Will Field
City planners sought to transfer land to the New London Development Corporation, a private nonprofit organization, which in turn would develop the land as a new facility for Pfizer. [read post]
20 Sep 2024, 2:25 am by H. Juanita Beecher, FortneyScott
Meanwhile, Pfizer—like the law firms challenged by Edward Blum—had clarified that all students were eligible to apply to the program. [read post]
20 Sep 2024, 2:25 am by H. Juanita Beecher, FortneyScott
Meanwhile, Pfizer—like the law firms challenged by Edward Blum—had clarified that all students were eligible to apply to the program. [read post]
16 Jul 2015, 4:00 am by Martin Kratz
Pfizer Ireland Pharmaceuticals 2006 FC 1465, where Lilly sought to impeach Pfizer’s patent on the Cialis drug and sought to get access to communications between the inventors and the U.K. [read post]
5 May 2021, 9:34 am by Kluwer Patent blogger
Last week, Pfizer announced its vaccine generated revenues of almost 3 billion euros in the first three months of 2021 and is expected to hit 21 billion euros this year, accounting for more than one third of Pfizer’s sales. [read post]
28 Oct 2009, 7:15 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: US: Senate Judiciary Committee passes amended Preserve Access to Affordable Generics Act (S.396) banning pay-for-delay settlements (Patent Baristas) Vigamox (Moxifloxacin) – US: District Court S D New York finds Teva infringed Alcon’s patent covering Vigamox (Patent Docs) (IP Factor) Alphagan (Brimonidine) – US:… [read post]
27 Jan 2012, 4:00 am
So many people have been emailing the IPKat to ask him if he has seen yesterday's General Court decision in Case T-332/10 Viaguara v OHIM - Pfizer (VIAGUARA) that he's beginning to worry if they are trying to tell him something. [read post]
20 May 2009, 5:18 am
: Dr Reddy’s post grant opposition against Pfizer’s Champix patent (Spicy IP) Tanzania generic pharma sector set for growth (Afro-IP) US: ACLU, PUBPAT and others file lawsuit challenging constitutionality of patents on human genes associated with breast and ovarian cancer: Association for Molecular Pathology et al v USPTO et al (Patent Baristas) (Ars Technica) (Patently-O) (IP Watchdog) (The Prior Art) (Patent Docs) (Patents4Life) US: Obvious-type double patenting and… [read post]
8 Jul 2012, 5:42 am by Schachtman
  So now, the study that formed the basis for the original ruling against Pfizer floats aimlessly as a derelict on the sea of science. [read post]
29 Dec 2010, 2:57 am by Marie Louise
Pfizer Ltd (Kluwer Patent Blog) Boniva (Ibandronate) – US: Roche dodges Cobalt invalidity contention in Boniva patent suit (Patent Docs) Boniva (Ibandronate) – US: Hoffman-La Roche files patent infringement suit against Mutual Pharmaceutical Company following Para IV certification filing (Patent Docs) Botox (Botulinum) – EU: General Court confirms declarations of invalidity of BOTOLIST and BOTOCYL filed by Allergan: T-345/08 and T-357-08 (Class 46) Detrol (Tolterodine)… [read post]
5 May 2021, 9:34 am by Kluwer Patent blogger
Last week, Pfizer announced its vaccine generated revenues of almost 3 billion euros in the first three months of 2021 and is expected to hit 21 billion euros this year, accounting for more than one third of Pfizer’s sales. [read post]
27 Jan 2010, 3:00 am
Kappos (Patent Docs) US: Calculating PTA: PTO to offer ‘guidance for expediting requests’ (Patently-O) US: Senate votes against Bill allowing Americans to import prescription drugs (Pharmacapsules@Gowlings) US: Governors write President in support of 12-year data exclusivity period (Patent Docs) US: Obama moving to renegotiate biologics exclusivity period (Pharmacapsules@Gowlings) US: Law Professors Adelman and Holman contend that data exclusivity is secondary issue in follow-on… [read post]